POCI · NASDAQ · Medical - Instruments & Supplies

Precision Optics

Designs and manufactures medical-imaging systems and optical components for defence and aerospace.

$4.40
After-hours close0.00 (0.00%)
At close$4.40(−0.68%)
Loading prices…

Profile

Precision Optics Corporation, Inc.POCIHealth Care

Produces medical-imaging systems and miniature optical components, then carries customer programs from development into manufacturing. Its operating areas combine systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro-optics laboratory for medical and defence/aerospace applications.

Designs and manufactures miniature optical systems for medical imaging and defence/aerospace uses. Its systems manufacturing, engineering and product development, Ross Optical components and assemblies, and micro-optics laboratory connect customer programs from concept through production.

Medical products include endoscopes, endocouplers, CMOS-based digital-imaging endoscopes, custom imaging and illumination products, Microprecision lenses, and complete medical devices. Ross Optical supplies lenses, prisms, mirrors, windows, coatings, and mechano-optical assemblies to defence, medical, and industrial applications.

Operations are concentrated in Massachusetts, with additional facilities in Texas and Maine. The business depends on customer programs advancing from engineering work to later-volume manufacture and on serving regulated medical-device and defence/aerospace applications.

Company facts

CEODr. Joseph (Joe) Forkey
ListedNov 16, 2022
ExchangeNASDAQ
HeadquartersLittleton, MA
CountryUnited States
Employees90
CIK0000867840
ISINUS7402944000

Key statistics

Market cap$48.2M
EPS (ttm)−$0.6639
P/E (ttm)−6.63
ROE-37.5%
P/B1.71
P/S1.66
Dividend yield
Beta0.37vs XLV 0.31

Year to date +3.5% · Average volume (30d) 43.8K

Analysts

No analyst consensus on record.

Earnings

EPS

Estimate−$0.06
ReportedDue Sep 28, 2026

Revenue

Estimate$7.1M
ReportedDue Sep 28, 2026

History

Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseNext session
May 13, 2026Q3 FY26−$0.06−$0.01+83.3%$7.1M$8.7M+21.7%+3.91%
Feb 17, 2026Q2 FY26−$0.23$7.4M−0.64%
Sep 29, 2025Q4 FY25−$0.18$6.2M−0.91%
May 15, 2025Q3 FY25−$0.30$4.2M−5.24%
View details

Financial highlights

12 quartersQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$4.5M$4.2M$6.2M$6.7M$7.4M$8.7M
Gross profit$1.1M$418.0K$799.2K$946.4K$204.7K$2.1M
Operating income−$910.0K−$2.0M−$1.4M−$1.6M−$1.7M−$64.5K
Net income−$969.7K−$2.1M−$1.4M−$1.6M−$1.8M−$108.3K
Diluted EPS−$0.15−$0.30−$0.21−$0.21−$0.23−$0.01
Gross margin23.6%10.0%12.9%14.2%2.8%23.6%
Operating margin-20.1%-48.7%-21.9%-23.9%-23.6%-0.7%

Fiscal years (4-quarter sums)FY21 $10.7M · FY22 $15.7M · FY23 $21.0M · FY24 $19.1M · FY25 $19.1M

Revenue by product · Q3 FY26

Engineering Design Services$1.1M · 100%

Balance sheet, Mar 31, 2026Cash & short-term investments $10.7M · Total debt $4.3M · Total assets $33.7M · Shareholders' equity $20.1M

Dividends

No dividends on record.

Ownership

Institutions 35.37%3.87M sharesInsiders 5.30%580.0K sharesOther 59.33%6.49M shares

Shares outstanding 10.94M · Float 7.94M · 72.6% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Needham Investment Management L.L.C.1.67M15.30%13GMay 14, 2026
Brian L. Pessin550.7K5.00%13DMar 31, 2026
Teller Richard E420.3K5.45%13GNov 21, 2025
Myda Advisors LLC400.0K3.65%13FMay 14, 2026
Peter H. Woodward · director342.6K3.13%Form 4May 20, 2025

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Mar 30, 2026Joseph Trautofficer: Chief Operating Officer+41,666$3.60
Mar 30, 2026Joseph Norman Forkeydirector, officer: Chief Executive Officer+1,388$3.60
Mar 30, 2026Wayne M. Collofficer: Chief Financial Officer+20,833$3.60
View details

Peers

  • LightPath Technologies

    Precision optical components and assemblies for medical and defense uses

  • Teledyne Technologies

    Digital imaging and aerospace/defense systems for high-reliability markets

  • Stryker

    Surgical endoscopy platforms and camera systems for clinical procedures

  • CONMED

    Single-use and capital endoscopic products for surgical procedures

CompareAfter-hours close

CompanyPriceChange
Precision Optics$4.400.00%$48.2M1.7+107.8%
LightPath Technologies$11.20−0.21%$705.1M11.2+108.9%
Teledyne Technologies$621.96+0.02%$28.83B30.024.44.5+9.8%
Stryker$334.18+1.06%$126.77B34.320.64.9+9.4%
CONMED$49.53−1.06%$1.50B27.011.21.1+0.3%
Median30.020.64.7+9.6%